WallStSmart
SLAB

Silicon Laboratories Inc

NASDAQ: SLAB · TECHNOLOGY · SEMICONDUCTORS

$217.19
+0.69% today

Updated 2026-04-29

Market cap
$7.16B
P/E ratio
P/S ratio
9.12x
EPS (TTM)
$-1.98
Dividend yield
52W range
$102 – $218
Volume
0.5M

Silicon Laboratories Inc (SLAB) Earnings

Quarterly earnings history, analyst estimates, and stock price reaction.

EPS beat streak
8 of 8
Last 8 quarters
Avg EPS surprise
+9.6%
Last 4 quarters
Revenue YoY growth
+25.2%
Most recent quarter
EPS YoY growth
+609.1%
Most recent quarter

Earnings surprise history (last 12 quarters)

Beat estimate Missed estimate

Quarterly EPS and revenue trend

Quarterly revenue EPS (diluted)

How the stock reacts to earnings

Avg 1-day reaction
+14.7%
Last 3 reports
Positive reaction rate
67%
2 of 3 quarters
Largest single-day move
+50.2%
2026-02-04
Report dateEPS actualSurpriseClose beforeClose after1-day reaction
2026-02-04$0.56+1.8%$136.62$205.22+50.2%
2025-11-04$0.32+3.2%$127.96$129.51+1.2%
2025-08-05$0.11+22.2%$133.55$123.76-7.3%

Quarterly earnings history

Fiscal quarter endingEPS estimateEPS actualSurpriseRevenueYoY revenue
2025-12-31$0.55$0.56+1.8%$208.21M+25.2%
2025-09-30$0.31$0.32+3.2%$206.00M+23.8%
2025-06-30$0.09$0.11+22.2%$192.84M+32.7%
2025-03-31$-0.09$-0.08+11.1%$177.71M+67.1%
2024-12-31$-0.11$-0.11+0.0%$166.25M+91.4%
2024-09-30$-0.21$-0.13+38.1%$166.40M-18.3%
2024-06-30$-0.64$-0.56+12.5%$145.37M-40.6%
2024-03-31$-0.98$-0.92+6.1%$106.38M
2023-12-31$-1.43$-1.19+16.8%$86.84M
2023-09-30$0.61$0.62+1.6%$203.76M
2023-06-30$1.03$1.04+1.0%$244.87M

Frequently asked questions

Has Silicon Laboratories Inc beaten earnings estimates?
Silicon Laboratories Inc has beaten Wall Street EPS estimates in 8 of its last 8 quarterly reports, with an average EPS surprise of +9.6% over the last 4 quarters.
How does SLAB stock react to earnings?
SLAB stock has moved an average of +14.7% in the trading day following earnings over its last 3 reports, with positive reactions in 67% of those quarters.
What is Silicon Laboratories Inc's revenue growth rate?
Silicon Laboratories Inc reported year-over-year revenue growth of +25.2% in its most recent quarter, with EPS growing +609.1% year-over-year.